UNPA – BREAKING / HHS sends recommendation to DEA to reschedule marijuana
Aug 31, 2023
From: Loren Israelsen <loren@unpa.com>
Date: Thu, Aug 31, 2023 at 8:09 AM
Subject: UNPA — BREAKING / HHS sends recommendation to DEA to reschedule marijuana
To: UNPA HE/C Committee Members <heidi@unpa.com>
Dear Colleagues —
In breaking news yesterday, the Department of Health and Human Services has sent recommendations to the DEA to reschedule marijuana as a Schedule III substance. Currently, marijuana is Schedule I. This action was taken pursuant to an October 2022 request letter from President Biden asking the Secretary of HHS and the Attorney General to review how marijuana is currently scheduled under federal law.
The immediate effect was a jump in publicly traded cannabis stocks. Whether this will have any effect on FDA’s views with respect to the status of CBD/hemp extracts remains to be seen.
We will be following this closely and keep you posted on developments.
Loren Israelsen visits with Mike Kauffman, President of Facilities Consulting NW, and discusses the importance of facility design in achieving GMP compliance. Mike
The U.S. Food and Drug Administration (FDA) published a draft guidance on the submission of new dietary ingredient notification (NDIN) master files. The
